Zosano Pharma Corporation (ZSAN) Stock Price Up 10.5%
Zosano Pharma Corporation (NASDAQ:ZSAN) shares rose 10.5% during mid-day trading on Friday . The company traded as high as $0.96 and last traded at $0.93, with a volume of 1,025,679 shares trading hands. The stock had previously closed at $0.84.
Separately, ValuEngine upgraded Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 6th.
The company’s market capitalization is $36.40 million. The stock’s 50-day moving average price is $1.05 and its 200 day moving average price is $1.54.
Zosano Pharma Corporation (NASDAQ:ZSAN) last announced its earnings results on Thursday, August 10th. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.02. During the same quarter last year, the company earned ($0.54) earnings per share. On average, equities analysts forecast that Zosano Pharma Corporation will post ($0.79) EPS for the current fiscal year.
A number of hedge funds have recently made changes to their positions in the stock. Northern Trust Corp boosted its stake in shares of Zosano Pharma Corporation by 591.4% in the second quarter. Northern Trust Corp now owns 79,234 shares of the biotechnology company’s stock valued at $112,000 after buying an additional 67,774 shares during the period. Granite Point Capital Management L.P. bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $285,000. Victory Capital Management Inc. bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $449,000. Nexthera Capital LP bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $950,000. Finally, Perceptive Advisors LLC bought a new stake in shares of Zosano Pharma Corporation during the first quarter valued at about $950,000. 22.66% of the stock is currently owned by institutional investors and hedge funds.
Zosano Pharma Corporation Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.